CoreLab Partners Showcases Technologies at 47th Annual DIA Meeting
CoreLab Partners
will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.
“I am pleased to announce that as a part of an on-going commitment to our sponsor partners to deliver the highest possible quality through a cost effective, technologically driven process, we are positioned to launch another series of enabling solutions in both our ImagEngine SM and WebHeart platforms”, said CoreLab Partners’ President and CEO, Dr. Mike Woehle . “Our proprietary advanced imaging application, ImagEngineSM, will perform 3D and volumetric measurements while incorporating multi-planer reconstruction tools with lesion propagation which will expand our therapeutic reach and addresses the growing needs for this type of image analysis going forward,” added Woehler.
CoreLab Partners invites you to learn more about their comprehensive suite of service capabilities and new technological solutions at booth #1035 at the 47th Annual DIA meeting in Chicago, Illinois.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
